Tirzepatide 2.5mg monthly treatment

What is Tirzepatide?

Tirzepatide is the active ingredient in Mounjareo. Tirzepatide injections are administered subcutaneously for Type 2 Diabetes A1C reduction and glycemic control, as well as chronic weight management treatment.

Benefits

Treatment benefits will vary by individual, but may include: enhanced insulin secretion, improved insulin sensitivity, reduced appetite, feeling a sense of fullness for longer durations after eating (delayed gastric emptying), and increased fat-burning mechanisms which may result in weight loss. Additional therapeutic benefits related to improved blood sugar levels include weight management.

Off-Label Use Disclosure: Tirzepatide is currently FDA approved for the management of type 2 diabetes. Any use of Tirzepatide for purposes other than management of type 2 diabetes is considered "off label" use. 

VMHC Tirzepatide is combined with B12 for energy, while also boosting metabolism and improving sleep cycle regulation.

Home Kit Includes:

• 1 month supply of Tirzepatide/B12 Combination Injection.
• Doses change dependent on the month and tolerability 
• 4 Pre-filled Syringes
• Alcohol Pads
• Health Care Provider Consultation [online]
• Educational Pamphlet

Administration:
Subcutaneous (Sub-q) Injection, self-administered in fatty abdominal area, back of arm or thigh.

Frequency: Once  a week taken on the same day each week, any time of day, with or without food. SEE INGREDIENTS BELOW

Benefits:

• Weight Loss.
• Energy and Metabolism booster.
• Improves Mood and sleep.
• May improve Blood Pressure.
• May improve cholesterol.
• Improves Blood Sugar

We promote a Healthy Lifestyle
Diet and Exercise: Portion control. Finding Healthier alternatives

Most Common Side Effect: Nausea, Vomitting, Diarrhea and or Constipation.

Please call our office for any additional questions or concerns. 864-358-9278.